gamma-Aminobutyric Acid-ergic Agonist [EPC]

gamma-Aminobutyric Acid-ergic Agonist [EPC] was reported 89408 times

Drugs of the gamma-Aminobutyric Acid-ergic Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 IMPLANT SITE EXTRAVASATION 340 0.4326
1 IMPLANT SITE EROSION 126 0.4286
2 GAIT SPASTIC 132 0.3848
3 MUSCLE SPASTICITY 3015 0.2451
4 NEEDLE FATIGUE 102 0.2232
5 IMPLANT SITE INFECTION 502 0.2156
6 DEVICE DAMAGE 148 0.1857
7 EPIDURAL LIPOMATOSIS 56 0.1628
8 RELAPSING-REMITTING MULTIPLE SCLEROSIS 138 0.1597
9 CEREBROSPINAL FLUID LEAKAGE 289 0.1563
10 MEDICAL DEVICE SITE INFECTION 93 0.1498
11 IMPLANT SITE SWELLING 143 0.1403
12 DEVICE BATTERY ISSUE 79 0.1201
13 DEVICE INFUSION ISSUE 243 0.0979
14 PROGRESSIVE MULTIPLE SCLEROSIS 112 0.0970
15 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 165 0.0877
16 NEUROGENIC BLADDER 172 0.0814
17 SOFT TISSUE INJURY 59 0.0779
18 CLONUS 205 0.0748
19 DEVICE ALARM ISSUE 134 0.0737
20 JC POLYOMAVIRUS TEST POSITIVE 83 0.0709
21 HYPERTONIA 404 0.0705
22 INFUSION SITE MASS 70 0.0644
23 BAND SENSATION 81 0.0638
24 CONSCIOUSNESS FLUCTUATING 65 0.0623
25 MONOPARESIS 112 0.0618
26 SEROMA 75 0.0590
27 IMPLANT SITE ERYTHEMA 60 0.0579
28 HYPERTONIC BLADDER 160 0.0553
29 POST LUMBAR PUNCTURE SYNDROME 57 0.0548
30 PERONEAL NERVE PALSY 308 0.0541
31 B-LYMPHOCYTE COUNT DECREASED 72 0.0529
32 TRIGEMINAL NEURALGIA 209 0.0519
33 MULTIPLE SCLEROSIS RELAPSE 3432 0.0500
34 MULTIPLE SCLEROSIS 2350 0.0491
35 HYPOTONIA 488 0.0488
36 ELECTROENCEPHALOGRAM ABNORMAL 154 0.0487
37 DEVICE KINK 170 0.0466
38 AREFLEXIA 124 0.0464
39 WOUND DEHISCENCE 156 0.0461
40 DECUBITUS ULCER 376 0.0461
41 LYMPHOCYTE PERCENTAGE DECREASED 61 0.0454
42 ENCEPHALOPATHY 1106 0.0450
43 DEVICE CONNECTION ISSUE 95 0.0450
44 METABOLIC ENCEPHALOPATHY 135 0.0449
45 NEUTROPHIL PERCENTAGE INCREASED 56 0.0444
46 TOXIC ENCEPHALOPATHY 222 0.0438
47 CYSTITIS NONINFECTIVE 58 0.0432
48 IMPLANT SITE PAIN 192 0.0429
49 PARAPARESIS 74 0.0415
50 RESPIRATORY DEPRESSION 498 0.0406
51 ENTHESOPATHY 61 0.0390
52 SPINAL CORD INJURY 68 0.0390
53 BRADYPNOEA 104 0.0385
54 NO THERAPEUTIC RESPONSE 466 0.0382
55 WHITE BLOOD CELL COUNT ABNORMAL 242 0.0379
56 URINE ANALYSIS ABNORMAL 111 0.0371
57 WHITE BLOOD CELLS URINE POSITIVE 68 0.0361
58 HYPOREFLEXIA 69 0.0359
59 MUSCLE CONTRACTURE 72 0.0355
60 WHEELCHAIR USER 157 0.0353
61 BLADDER SPASM 65 0.0347
62 DEVICE FAILURE 527 0.0346
63 AUTONOMIC NERVOUS SYSTEM IMBALANCE 101 0.0345
64 CENTRAL NERVOUS SYSTEM LESION 473 0.0344
65 MUSCLE TIGHTNESS 546 0.0337
66 CERVICAL SPINAL STENOSIS 57 0.0331
67 COMA SCALE ABNORMAL 95 0.0328
68 WALKING AID USER 215 0.0326
69 RADICULOPATHY 84 0.0318
70 SCOLIOSIS 195 0.0314
71 SEDATION COMPLICATION 80 0.0313
72 DYSAESTHESIA 96 0.0313
73 MENTAL STATUS CHANGES 869 0.0313
74 ESCHERICHIA URINARY TRACT INFECTION 129 0.0303
75 COMA 1435 0.0301
76 QUADRIPLEGIA 61 0.0296
77 BLADDER DISORDER 294 0.0296
78 JOINT NOISE 57 0.0290
79 MICTURITION URGENCY 330 0.0289
80 HYPERPARATHYROIDISM SECONDARY 72 0.0287
81 LOSS OF CONTROL OF LEGS 105 0.0277
82 PNEUMONIA ASPIRATION 690 0.0276
83 DECREASED INTEREST 162 0.0274
84 ATAXIA 324 0.0273
85 NEPHROGENIC ANAEMIA 124 0.0267
86 INTERVERTEBRAL DISC DISORDER 114 0.0267
87 UROSEPSIS 246 0.0266
88 MEDICAL DEVICE DISCOMFORT 81 0.0265
89 URINARY TRACT INFECTION BACTERIAL 67 0.0265
90 WITHDRAWAL SYNDROME 1092 0.0260
91 UNRESPONSIVE TO STIMULI 660 0.0255
92 BACTERIAL TEST POSITIVE 57 0.0255
93 REBOUND ACID HYPERSECRETION 77 0.0254
94 NEURALGIA 616 0.0253
95 MYOCLONUS 302 0.0253
96 BLOOD IMMUNOGLOBULIN G DECREASED 61 0.0246
97 DELIRIUM 850 0.0245
98 PERFORMANCE STATUS DECREASED 114 0.0244
99 BALANCE DISORDER 2096 0.0242
100 URINARY INCONTINENCE 708 0.0239
101 LYMPHOCYTE COUNT DECREASED 422 0.0238
102 JUVENILE IDIOPATHIC ARTHRITIS 58 0.0237
103 TEMPERATURE INTOLERANCE 243 0.0235
104 SUSPECTED SUICIDE 109 0.0232
105 CLUMSINESS 62 0.0227
106 HYPERREFLEXIA 79 0.0227
107 MUSCLE RIGIDITY 271 0.0226
108 DRUG WITHDRAWAL SYNDROME 1977 0.0225
109 PERSONALITY DISORDER 59 0.0225
110 PARAPLEGIA 65 0.0225
111 SKIN ABRASION 106 0.0224
112 ANAL INCONTINENCE 200 0.0222
113 HYPOKINESIA 322 0.0222
114 STATUS EPILEPTICUS 250 0.0221
115 CONCUSSION 171 0.0221
116 HOSTILITY 56 0.0220
117 SLEEP APNOEA SYNDROME 420 0.0220
118 LIPOMA 57 0.0220
119 MOTOR DYSFUNCTION 224 0.0220
120 GAIT DISTURBANCE 4202 0.0219
121 LUMBAR SPINAL STENOSIS 64 0.0219
122 NYSTAGMUS 116 0.0218
123 RESPIRATORY RATE DECREASED 68 0.0216
124 RESPIRATORY ACIDOSIS 85 0.0216
125 MONOPLEGIA 93 0.0214
126 URINARY TRACT INFECTION 3618 0.0212
127 MUSCULAR WEAKNESS 2410 0.0212
128 WRONG PATIENT RECEIVED PRODUCT 62 0.0212
129 PRE-EXISTING CONDITION IMPROVED 132 0.0211
130 INTERVERTEBRAL DISC DEGENERATION 195 0.0211
131 MUSCLE CONTRACTIONS INVOLUNTARY 74 0.0210
132 FAECAL INCONTINENCE 101 0.0210
133 SENSORY LOSS 168 0.0208
134 VITAMIN D DEFICIENCY 203 0.0208
135 COMPLICATION ASSOCIATED WITH DEVICE 300 0.0206
136 HALLUCINATIONS, MIXED 86 0.0204
137 ABASIA 505 0.0204
138 DEMYELINATION 83 0.0202
139 INCOHERENT 131 0.0202
140 DYSGRAPHIA 133 0.0202
141 INCONTINENCE 213 0.0201
142 FINE MOTOR SKILL DYSFUNCTION 58 0.0200
143 OPTIC NEURITIS 180 0.0198
144 POSTURE ABNORMAL 64 0.0197
145 NEUROTOXICITY 342 0.0195
146 MUSCLE SPASMS 3502 0.0191
147 SNORING 72 0.0190
148 URINARY TRACT DISORDER 85 0.0189
149 SEDATION 494 0.0188
150 COORDINATION ABNORMAL 263 0.0188
151 SPINAL OSTEOARTHRITIS 165 0.0188
152 HYPOVENTILATION 61 0.0187
153 MOBILITY DECREASED 1333 0.0185
154 SPINAL FUSION SURGERY 75 0.0185
155 MUSCULOSKELETAL STIFFNESS 1603 0.0183
156 HYPOTHERMIA 185 0.0183
157 DYSSTASIA 533 0.0182
158 POISONING DELIBERATE 172 0.0181
159 THERAPY CESSATION 925 0.0180
160 HAEMOGLOBIN INCREASED 82 0.0180
161 SENSORY DISTURBANCE 288 0.0179
162 FUNCTIONAL GASTROINTESTINAL DISORDER 62 0.0179
163 INTERVERTEBRAL DISC PROTRUSION 390 0.0178
164 MENINGITIS 118 0.0177
165 COMPLETED SUICIDE 1459 0.0175
166 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 58 0.0175
167 GRANULOMA 60 0.0173
168 CYSTITIS 549 0.0172
169 SPINAL COLUMN STENOSIS 81 0.0171
170 RED CELL DISTRIBUTION WIDTH INCREASED 71 0.0171
171 DEVICE OCCLUSION 240 0.0170
172 FALL 5607 0.0168
173 HEMIPARESIS 285 0.0168
174 PARALYSIS 240 0.0167
175 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 138 0.0167
176 SPINAL STENOSIS 69 0.0167
177 BURSITIS 201 0.0166
178 NERVE COMPRESSION 152 0.0165
179 URINARY RETENTION 548 0.0164
180 MOVEMENT DISORDER 522 0.0162
181 DYSTONIA 315 0.0162
182 KLEBSIELLA INFECTION 82 0.0162
183 MUSCLE TWITCHING 371 0.0161
184 HYPOAESTHESIA 2400 0.0160
185 APNOEA 124 0.0159
186 THYROID MASS 61 0.0159
187 FEELING OF BODY TEMPERATURE CHANGE 93 0.0159
188 COLITIS MICROSCOPIC 75 0.0158
189 HYPERAESTHESIA 130 0.0158
190 DEPRESSED LEVEL OF CONSCIOUSNESS 626 0.0158
191 POST-TRAUMATIC STRESS DISORDER 106 0.0158
192 EAR PRURITUS 55 0.0157
193 FLUSHING 1588 0.0156
194 VULVOVAGINAL MYCOTIC INFECTION 61 0.0155
195 ROTATOR CUFF SYNDROME 199 0.0155
196 ANKLE FRACTURE 239 0.0154
197 URINE ABNORMALITY 70 0.0154
198 GRAND MAL CONVULSION 142 0.0154
199 MAJOR DEPRESSION 112 0.0153
200 SINUS BRADYCARDIA 148 0.0153
201 LIMB DISCOMFORT 465 0.0150
202 BEDRIDDEN 197 0.0150
203 TENDERNESS 156 0.0150
204 PRODUCT ADMINISTRATION INTERRUPTED 117 0.0149
205 MIOSIS 119 0.0148
206 FACE INJURY 56 0.0147
207 MEMORY IMPAIRMENT 2023 0.0147
208 DYSARTHRIA 554 0.0147
209 EUPHORIC MOOD 150 0.0146
210 SPINAL PAIN 171 0.0146
211 NOCTURIA 177 0.0146
212 CEREBRAL ATROPHY 58 0.0145
213 DIPLOPIA 377 0.0145
214 SEIZURE 1673 0.0145
215 COGNITIVE DISORDER 673 0.0144
216 GASTROINTESTINAL MOTILITY DISORDER 77 0.0144
217 ARTERIOSCLEROSIS CORONARY ARTERY 95 0.0143
218 CEREBRAL DISORDER 106 0.0143
219 TIBIA FRACTURE 67 0.0143
220 SOMNOLENCE 2842 0.0141
221 BRUXISM 76 0.0141
222 MUSCULOSKELETAL DISORDER 268 0.0141
223 LYMPHOPENIA 199 0.0141
224 GENERALISED TONIC-CLONIC SEIZURE 232 0.0140
225 ATELECTASIS 134 0.0139
226 SPINAL DISORDER 131 0.0138
227 PURULENT DISCHARGE 59 0.0138
228 SPINAL OPERATION 170 0.0138
229 PARTIAL SEIZURES 72 0.0137
230 IMMOBILE 60 0.0137
231 MUSCLE FATIGUE 58 0.0137
232 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 68 0.0136
233 DYSKINESIA 553 0.0136
234 URINE ODOUR ABNORMAL 80 0.0136
235 ASPHYXIA 111 0.0136
236 BACK DISORDER 218 0.0134
237 MUSCLE ATROPHY 169 0.0133
238 FIBROMYALGIA 324 0.0133
239 RESTLESS LEGS SYNDROME 242 0.0133
240 IMPAIRED GASTRIC EMPTYING 181 0.0133
241 GAIT INABILITY 443 0.0132
242 FACIAL PAIN 118 0.0132
243 POSTOPERATIVE WOUND INFECTION 89 0.0132
244 SKIN LACERATION 143 0.0131
245 EYE MOVEMENT DISORDER 90 0.0131
246 HYPERTHERMIA 100 0.0131
247 INFLUENZA LIKE ILLNESS 1077 0.0131
248 FOOT FRACTURE 248 0.0131
249 BRAIN INJURY 131 0.0131
250 HYPERAMMONAEMIA 65 0.0130
251 VITAMIN D DECREASED 111 0.0130
252 RENAL CYST 103 0.0130
253 CATATONIA 68 0.0129
254 NEPHROLITHIASIS 590 0.0129
255 HEMIPLEGIA 107 0.0128
256 NERVE INJURY 143 0.0128
257 TOXICITY TO VARIOUS AGENTS 2168 0.0128
258 BODY TEMPERATURE INCREASED 262 0.0128
259 ALTERED STATE OF CONSCIOUSNESS 276 0.0127
260 SEASONAL ALLERGY 180 0.0127
261 STAPHYLOCOCCAL INFECTION 418 0.0127
262 OBESITY 201 0.0126
263 SCIATICA 201 0.0126
264 HEAD INJURY 399 0.0126
265 LETHARGY 722 0.0125
266 LOWER LIMB FRACTURE 241 0.0125
267 ONYCHOMYCOSIS 55 0.0125
268 HYPERSOMNIA 357 0.0124
269 NECK PAIN 695 0.0124
270 HICCUPS 102 0.0124
271 BRADYCARDIA 658 0.0124
272 CONVULSION 704 0.0123
273 RIB FRACTURE 252 0.0122
274 HYPERVENTILATION 71 0.0122
275 NEUROLOGICAL SYMPTOM 70 0.0122
276 SPEECH DISORDER 641 0.0122
277 WOUND INFECTION 133 0.0121
278 ASPIRATION 133 0.0121
279 RESPIRATORY ARREST 334 0.0121
280 VAGINAL INFECTION 57 0.0121
281 POST PROCEDURAL INFECTION 98 0.0120
282 FAECALOMA 66 0.0120
283 POLLAKIURIA 502 0.0120
284 LIGAMENT SPRAIN 119 0.0120
285 FEELING DRUNK 89 0.0120
286 CHRONIC KIDNEY DISEASE 909 0.0120
287 DIABETIC NEUROPATHY 59 0.0119
288 LYMPHOEDEMA 82 0.0118
289 TREMOR 1962 0.0118
290 DISORIENTATION 467 0.0118
291 POOR QUALITY SLEEP 253 0.0117
292 MIGRAINE 1120 0.0117
293 PERIPHERAL COLDNESS 161 0.0117
294 END STAGE RENAL DISEASE 213 0.0117
295 THERAPEUTIC RESPONSE UNEXPECTED 523 0.0116
296 APHASIA 351 0.0116
297 GASTROOESOPHAGEAL REFLUX DISEASE 931 0.0116
298 SEROTONIN SYNDROME 221 0.0115
299 HAND FRACTURE 80 0.0113
300 PARAESTHESIA 1776 0.0113
301 SOMNAMBULISM 74 0.0113
302 MEDICAL DEVICE COMPLICATION 83 0.0112
303 MENISCUS INJURY 69 0.0112
304 INTENTIONAL OVERDOSE 717 0.0112
305 BURNING SENSATION 782 0.0111
306 CONFUSIONAL STATE 1802 0.0111
307 HEPATIC STEATOSIS 207 0.0111
308 MUSCLE DISORDER 90 0.0111
309 INITIAL INSOMNIA 114 0.0111
310 ACTIVITIES OF DAILY LIVING IMPAIRED 219 0.0110
311 NEUROLEPTIC MALIGNANT SYNDROME 131 0.0110
312 CARPAL TUNNEL SYNDROME 154 0.0110
313 KIDNEY INFECTION 215 0.0109
314 DEPRESSION 2490 0.0109
315 BACK PAIN 2536 0.0109
316 AGITATION 797 0.0108
317 FORMICATION 75 0.0108
318 GRIP STRENGTH DECREASED 94 0.0107
319 HALLUCINATION 804 0.0107
320 BLOOD PRESSURE SYSTOLIC INCREASED 208 0.0107
321 DEVICE RELATED INFECTION 164 0.0106
322 HAEMODYNAMIC INSTABILITY 81 0.0106
323 ACUTE RESPIRATORY FAILURE 204 0.0106
324 COVID-19 PNEUMONIA 125 0.0106
325 HALLUCINATION, VISUAL 223 0.0106
326 PRESCRIBED UNDERDOSE 210 0.0105
327 INGUINAL HERNIA 64 0.0105
328 JOINT DISLOCATION 111 0.0105
329 AMNESIA 683 0.0105
330 MUSCULOSKELETAL DISCOMFORT 180 0.0104
331 ROAD TRAFFIC ACCIDENT 437 0.0104
332 INSOMNIA 2766 0.0104
333 DYSURIA 379 0.0103
334 IMPAIRED DRIVING ABILITY 117 0.0103
335 INCREASED TENDENCY TO BRUISE 94 0.0102
336 CLOSTRIDIUM DIFFICILE COLITIS 108 0.0102
337 AFFECTIVE DISORDER 80 0.0102
338 PARANOIA 175 0.0101
339 PHOTOPSIA 64 0.0101
340 CELLULITIS 510 0.0101
341 THYROID DISORDER 156 0.0101
342 BLOOD POTASSIUM DECREASED 304 0.0101
343 BRADYPHRENIA 66 0.0101
344 OSTEOMYELITIS 182 0.0100
345 CONCOMITANT DISEASE AGGRAVATED 62 0.0100
346 OSTEOARTHRITIS 425 0.0100
347 DYSPHAGIA 951 0.0100
348 JOINT INJURY 214 0.0100
349 ORAL HERPES 195 0.0100
350 IMMUNOSUPPRESSION 88 0.0100
351 LIMB INJURY 269 0.0099
352 INADEQUATE ANALGESIA 84 0.0099
353 FEELING HOT 604 0.0098
354 BRAIN FOG 154 0.0098
355 MUSCLE STRAIN 85 0.0098
356 MIDDLE INSOMNIA 183 0.0098
357 LOSS OF CONSCIOUSNESS 1253 0.0098
358 THERAPY NON-RESPONDER 438 0.0097
359 HEART RATE DECREASED 342 0.0097
360 DISTURBANCE IN ATTENTION 525 0.0097
361 BLOOD MAGNESIUM DECREASED 84 0.0097
362 HERPES VIRUS INFECTION 56 0.0097
363 PHARYNGEAL SWELLING 95 0.0097
364 SCAR 166 0.0097
365 PSEUDOMONAS INFECTION 83 0.0097
366 PROCEDURAL COMPLICATION 74 0.0096
367 PAIN 5904 0.0096
368 SUPRAVENTRICULAR TACHYCARDIA 92 0.0096
369 POST PROCEDURAL COMPLICATION 184 0.0096
370 EAR INFECTION 253 0.0095
371 HAEMATOCRIT DECREASED 188 0.0095
372 DEVICE DISLOCATION 412 0.0095
373 CANDIDA INFECTION 160 0.0095
374 GENERAL SYMPTOM 71 0.0095
375 HYPERHIDROSIS 1218 0.0094
376 HIP FRACTURE 304 0.0094
377 WRIST FRACTURE 112 0.0093
378 ASTHENIA 3511 0.0093
379 SPINAL COMPRESSION FRACTURE 77 0.0093
380 MULTIPLE ALLERGIES 73 0.0093
381 SKIN REACTION 131 0.0093
382 PULMONARY CONGESTION 122 0.0092
383 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 443 0.0092
384 BLEPHAROSPASM 58 0.0092
385 PAIN IN EXTREMITY 2708 0.0092
386 CONTUSION 883 0.0092
387 SINUS DISORDER 181 0.0091
388 DROOLING 63 0.0091
389 BACK INJURY 99 0.0091
390 BRONCHITIS 673 0.0091
391 NEUTROPHIL COUNT INCREASED 93 0.0091
392 ESCHERICHIA INFECTION 74 0.0090
393 MENTAL IMPAIRMENT 218 0.0090
394 RESPIRATORY FAILURE 655 0.0090
395 OVERDOSE 1936 0.0090
396 GASTROINTESTINAL INFECTION 80 0.0089
397 OSTEOPENIA 135 0.0089
398 TENDONITIS 137 0.0088
399 BIPOLAR DISORDER 96 0.0088
400 POISONING 110 0.0087
401 GASTROENTERITIS VIRAL 158 0.0087
402 FEELING COLD 243 0.0087
403 HYPERLIPIDAEMIA 104 0.0087
404 RESPIRATORY DISTRESS 240 0.0087
405 OSTEOPOROSIS 357 0.0087
406 ECONOMIC PROBLEM 131 0.0086
407 THERAPEUTIC RESPONSE DECREASED 524 0.0086
408 MANIA 142 0.0086
409 COVID-19 1514 0.0086
410 SLEEP DISORDER 609 0.0086
411 UTERINE LEIOMYOMA 63 0.0086
412 SEPSIS 958 0.0086
413 MASS 120 0.0086
414 RESPIRATION ABNORMAL 59 0.0086
415 RESPIRATORY RATE INCREASED 76 0.0086
416 GROIN PAIN 75 0.0085
417 PRODUCT DOSE OMISSION 556 0.0085
418 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 467 0.0085
419 BODY HEIGHT DECREASED 91 0.0085
420 DEPRESSED MOOD 448 0.0085
421 DEVICE ISSUE 760 0.0085
422 PSYCHOTIC DISORDER 250 0.0085
423 DELUSION 131 0.0084
424 CONSTIPATION 1839 0.0084
425 UPPER RESPIRATORY TRACT INFECTION 389 0.0084
426 IMMUNODEFICIENCY 125 0.0084
427 HERPES ZOSTER 481 0.0084
428 MUSCULOSKELETAL PAIN 438 0.0084
429 EXOSTOSIS 76 0.0083
430 LACERATION 78 0.0083
431 SKIN INFECTION 93 0.0083
432 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 142 0.0083
433 SUICIDE ATTEMPT 500 0.0082
434 TACHYCARDIA 732 0.0082
435 LOCALISED INFECTION 199 0.0082
436 MYDRIASIS 105 0.0082
437 FATIGUE 6360 0.0082
438 LEUKOCYTOSIS 146 0.0081
439 DENTAL CARIES 89 0.0080
440 CONDITION AGGRAVATED 2444 0.0080
441 SARS-COV-2 TEST POSITIVE 106 0.0080
442 INFECTION 1159 0.0080
443 FLANK PAIN 75 0.0080
444 SALIVARY HYPERSECRETION 80 0.0080
445 TOOTH INFECTION 105 0.0080
446 FEELING ABNORMAL 1895 0.0079
447 MUSCULOSKELETAL CHEST PAIN 122 0.0079
448 BLOOD PRESSURE DIASTOLIC DECREASED 58 0.0078
449 DECREASED IMMUNE RESPONSIVENESS 77 0.0078
450 DRUG SCREEN POSITIVE 62 0.0078
451 PELVIC FRACTURE 61 0.0078
452 HYPOAESTHESIA ORAL 118 0.0078
453 HIATUS HERNIA 101 0.0078
454 BLOOD SODIUM DECREASED 147 0.0078
455 FRUSTRATION TOLERANCE DECREASED 63 0.0078
456 UPPER LIMB FRACTURE 155 0.0078
457 LABORATORY TEST ABNORMAL 229 0.0078
458 ANXIETY 2207 0.0077
459 SPINAL FRACTURE 155 0.0077
460 CHILLS 905 0.0077
461 SINUSITIS 791 0.0077
462 DEVICE MALFUNCTION 541 0.0077
463 FURUNCLE 61 0.0077
464 IRRITABLE BOWEL SYNDROME 165 0.0077
465 UNEVALUABLE EVENT 582 0.0077
466 WOUND 215 0.0077
467 BLOOD URINE PRESENT 146 0.0077
468 HYPERTENSION 1626 0.0077
469 THINKING ABNORMAL 143 0.0077
470 VIRAL INFECTION 255 0.0077
471 VERTIGO 467 0.0077
472 TROPONIN INCREASED 58 0.0076
473 PYELONEPHRITIS 66 0.0076
474 INFUSION SITE ERYTHEMA 64 0.0076
475 EPILEPSY 232 0.0076
476 AFFECT LABILITY 73 0.0076
477 BOWEL MOVEMENT IRREGULARITY 58 0.0076
478 EAR PAIN 147 0.0076
479 CARDIOMEGALY 93 0.0076
480 TINNITUS 347 0.0075
481 SLUGGISHNESS 77 0.0075
482 INFUSION SITE PAIN 97 0.0075
483 HEART RATE INCREASED 745 0.0075
484 RED BLOOD CELL SEDIMENTATION RATE INCREASED 83 0.0075
485 PHOTOPHOBIA 141 0.0075
486 PRODUCT PRESCRIBING ERROR 178 0.0075
487 CRYING 271 0.0074
488 RESPIRATORY DISORDER 223 0.0074
489 POOR VENOUS ACCESS 77 0.0074
490 TOOTH FRACTURE 82 0.0074
491 CARDIO-RESPIRATORY ARREST 311 0.0074
492 COLD SWEAT 131 0.0074
493 BODY TEMPERATURE DECREASED 73 0.0074
494 PANIC ATTACK 270 0.0074
495 FEEDING DISORDER 150 0.0074
496 SCRATCH 78 0.0074
497 HYSTERECTOMY 64 0.0074
498 IRRITABILITY 444 0.0074
499 JOINT RANGE OF MOTION DECREASED 99 0.0074
500 ACCIDENTAL OVERDOSE 270 0.0074
501 DIZZINESS 3680 0.0074
502 WHITE BLOOD CELL COUNT INCREASED 283 0.0074
503 PNEUMONIA 2388 0.0074
504 INFLUENZA 821 0.0074
505 IMMUNE SYSTEM DISORDER 97 0.0074
506 DRY MOUTH 597 0.0074
507 RENAL INJURY 218 0.0073
508 BLOOD PRESSURE FLUCTUATION 176 0.0073
509 CLOSTRIDIUM DIFFICILE INFECTION 160 0.0073
510 CHOKING 143 0.0073
511 JOINT STIFFNESS 192 0.0073
512 GASTRIC DISORDER 251 0.0073
513 VISION BLURRED 1004 0.0073
514 BLOOD ALBUMIN DECREASED 58 0.0073
515 WHITE BLOOD CELL COUNT DECREASED 791 0.0073
516 HEADACHE 4571 0.0073
517 IMPAIRED HEALING 239 0.0073
518 DRUG TOXICITY 99 0.0073
519 CHROMATURIA 164 0.0073
520 CYST 90 0.0072
521 HIP ARTHROPLASTY 111 0.0072
522 ABNORMAL BEHAVIOUR 287 0.0072
523 ARTHRITIS 569 0.0072
524 FOOT DEFORMITY 80 0.0072
525 POLYURIA 59 0.0072
526 ACCIDENT 86 0.0072
527 DIVERTICULITIS 199 0.0072
528 DEVICE PHYSICAL PROPERTY ISSUE 55 0.0072
529 VISUAL IMPAIRMENT 888 0.0072
530 GLAUCOMA 138 0.0072
531 BACTERIAL INFECTION 133 0.0071
532 BLOOD CALCIUM DECREASED 80 0.0071
533 EAR DISCOMFORT 73 0.0071
534 NIGHTMARE 246 0.0071
535 CONTRAINDICATED PRODUCT ADMINISTERED 215 0.0071
536 WEIGHT FLUCTUATION 74 0.0071
537 HYPOTHYROIDISM 225 0.0070
538 FACIAL PARALYSIS 60 0.0070
539 HOT FLUSH 530 0.0070
540 CHOLELITHIASIS 230 0.0070
541 OXYGEN SATURATION DECREASED 393 0.0070
542 PSYCHOMOTOR HYPERACTIVITY 116 0.0070
543 RETCHING 149 0.0070
544 HALLUCINATION, AUDITORY 111 0.0070
545 DRY THROAT 71 0.0070
546 RENAL PAIN 74 0.0070
547 ANKYLOSING SPONDYLITIS 92 0.0070
548 AUTOIMMUNE DISORDER 68 0.0070
549 HEAD DISCOMFORT 123 0.0069
550 ERECTILE DYSFUNCTION 178 0.0069
551 RED BLOOD CELL COUNT DECREASED 196 0.0068
552 CORONARY ARTERY OCCLUSION 94 0.0068
553 DRUG INTERACTION 1087 0.0068
554 HYPOTENSION 1373 0.0068
555 UNDERDOSE 499 0.0068
556 DRUG LEVEL INCREASED 113 0.0068
557 IRON DEFICIENCY ANAEMIA 63 0.0068
558 NERVOUS SYSTEM DISORDER 213 0.0068
559 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 485 0.0068
560 THERAPY CHANGE 67 0.0068
561 THROAT IRRITATION 305 0.0068
562 TOOTHACHE 123 0.0068
563 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 60 0.0068
564 OROPHARYNGEAL PAIN 626 0.0068
565 MENTAL DISORDER 294 0.0067
566 FUNGAL INFECTION 225 0.0067
567 NEUROPATHY PERIPHERAL 642 0.0067
568 BLOOD PRESSURE DECREASED 448 0.0067
569 BACTERAEMIA 80 0.0067
570 PERIPHERAL SWELLING 1038 0.0067
571 HYPOPHAGIA 172 0.0067
572 CARDIAC ARREST 553 0.0067
573 RESTLESSNESS 245 0.0067
574 BLOOD PRESSURE ABNORMAL 133 0.0067
575 UPPER-AIRWAY COUGH SYNDROME 55 0.0067
576 HYPOXIA 235 0.0067
577 RESPIRATORY TRACT CONGESTION 106 0.0067
578 TOOTH DISORDER 148 0.0066
579 ACUTE KIDNEY INJURY 1017 0.0066
580 PYREXIA 2297 0.0066
581 URINE OUTPUT DECREASED 58 0.0066
582 HEPATIC ENZYME INCREASED 452 0.0066
583 DRUG EFFECT DECREASED 357 0.0066
584 TACHYPNOEA 90 0.0066
585 MALNUTRITION 74 0.0066
586 HAEMORRHOIDS 129 0.0066
587 GASTRITIS 174 0.0066
588 WEIGHT DECREASED 1844 0.0066
589 ABNORMAL DREAMS 182 0.0066
590 SMALL INTESTINAL OBSTRUCTION 81 0.0066
591 TRANSIENT ISCHAEMIC ATTACK 222 0.0066
592 NIGHT SWEATS 212 0.0066
593 CHOLECYSTECTOMY 75 0.0066
594 NASOPHARYNGITIS 1203 0.0065
595 DISABILITY 129 0.0065
596 BLINDNESS UNILATERAL 92 0.0065
597 APHONIA 91 0.0065
598 SURGERY 381 0.0065
599 RESPIRATORY TRACT INFECTION 169 0.0065
600 ORAL PAIN 145 0.0065
601 MITRAL VALVE INCOMPETENCE 73 0.0064
602 BLOOD PRESSURE INCREASED 986 0.0064
603 DRUG DOSE OMISSION 1063 0.0064
604 SKIN ULCER 166 0.0064
605 BASAL CELL CARCINOMA 100 0.0064
606 DYSPEPSIA 630 0.0064
607 CHOLECYSTITIS 76 0.0064
608 PHARYNGITIS STREPTOCOCCAL 69 0.0064
609 PRODUCT DOSE OMISSION IN ERROR 180 0.0064
610 VOMITING 2979 0.0063
611 BRAIN OEDEMA 80 0.0063
612 APPENDICITIS 59 0.0063
613 OEDEMA PERIPHERAL 769 0.0063
614 APATHY 92 0.0063
615 SINUS CONGESTION 85 0.0063
616 TOOTH ABSCESS 64 0.0063
617 LIVER FUNCTION TEST ABNORMAL 182 0.0063
618 DEHYDRATION 834 0.0062
619 PERSONALITY CHANGE 58 0.0062
620 SUICIDAL IDEATION 570 0.0062
621 ALOPECIA 1218 0.0062
622 KNEE OPERATION 61 0.0062
623 FEMUR FRACTURE 192 0.0062
624 FULL BLOOD COUNT ABNORMAL 65 0.0061
625 DERMATITIS CONTACT 70 0.0061
626 SINUS TACHYCARDIA 87 0.0061
627 ELECTROLYTE IMBALANCE 71 0.0061
628 DEEP VEIN THROMBOSIS 396 0.0061
629 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 317 0.0061
630 NAUSEA 4805 0.0061
631 HAEMATOMA 157 0.0061
632 ANHEDONIA 159 0.0060
633 BLOOD CHOLESTEROL INCREASED 282 0.0060
634 HYPOKALAEMIA 279 0.0060
635 DECREASED ACTIVITY 65 0.0060
636 SUBDURAL HAEMATOMA 86 0.0060
637 EYE PAIN 338 0.0060
638 KNEE ARTHROPLASTY 126 0.0060
639 DIZZINESS POSTURAL 58 0.0060
640 BLOOD UREA INCREASED 100 0.0060
641 SCAB 68 0.0060
642 HAEMATEMESIS 151 0.0060
643 NASAL CONGESTION 350 0.0059
644 ABDOMINAL DISCOMFORT 998 0.0059
645 RHINORRHOEA 384 0.0059
646 OEDEMA 322 0.0059
647 ELECTROCARDIOGRAM QT PROLONGED 213 0.0059
648 ABDOMINAL PAIN UPPER 1218 0.0059
649 COELIAC DISEASE 58 0.0059
650 RENAL TUBULAR NECROSIS 58 0.0059
651 MYALGIA 1005 0.0059
652 SPUTUM DISCOLOURED 56 0.0059
653 CHEST PAIN 1092 0.0059
654 SPLENOMEGALY 69 0.0059
655 ARTHROPATHY 327 0.0059
656 HOSPICE CARE 58 0.0059
657 DRUG EFFECT LESS THAN EXPECTED 87 0.0059
658 TUBULOINTERSTITIAL NEPHRITIS 110 0.0059
659 RHABDOMYOLYSIS 244 0.0058
660 ORAL CANDIDIASIS 77 0.0058
661 PETECHIAE 61 0.0058
662 RENAL FAILURE 776 0.0058
663 RHEUMATOID ARTHRITIS 661 0.0058
664 INTESTINAL OBSTRUCTION 219 0.0058
665 HEART RATE IRREGULAR 131 0.0058
666 INFLAMMATION 299 0.0058
667 PAIN IN JAW 164 0.0058
668 PULMONARY THROMBOSIS 63 0.0058
669 FLUID RETENTION 293 0.0058
670 MALAISE 2526 0.0058
671 SWELLING 539 0.0058
672 SNEEZING 129 0.0057
673 PRESCRIBED OVERDOSE 111 0.0057
674 BLOOD IRON DECREASED 68 0.0057
675 ILLNESS 590 0.0057
676 GASTROINTESTINAL DISORDER 513 0.0057
677 FEELING JITTERY 109 0.0057
678 ARTHRALGIA 2376 0.0057
679 DISCOMFORT 348 0.0057
680 SUBARACHNOID HAEMORRHAGE 58 0.0057
681 WEIGHT INCREASED 1275 0.0057
682 ORTHOSTATIC HYPOTENSION 99 0.0057
683 INJECTION SITE MASS 209 0.0056
684 DRUG INTOLERANCE 545 0.0056
685 PULMONARY EMBOLISM 536 0.0056
686 EATING DISORDER 120 0.0056
687 CHEST DISCOMFORT 577 0.0056
688 AGGRESSION 282 0.0056
689 ILEUS 70 0.0056
690 OVARIAN CYST 56 0.0056
691 MALIGNANT MELANOMA 75 0.0056
692 ULCER 89 0.0056
693 PALPITATIONS 654 0.0056
694 THERAPEUTIC RESPONSE SHORTENED 185 0.0056
695 IMPAIRED WORK ABILITY 119 0.0056
696 IMPAIRED QUALITY OF LIFE 80 0.0056
697 MOOD SWINGS 177 0.0055
698 JOINT SWELLING 670 0.0055
699 GASTROINTESTINAL PAIN 61 0.0055
700 BLOOD CREATINE PHOSPHOKINASE INCREASED 159 0.0055
701 INFUSION RELATED REACTION 365 0.0055
702 EYE INFECTION 62 0.0055
703 DYSPHONIA 321 0.0055
704 PHARYNGITIS 68 0.0055
705 SYNCOPE 548 0.0055
706 DRY EYE 273 0.0055
707 BONE DISORDER 99 0.0054
708 INSURANCE ISSUE 83 0.0054
709 HYPONATRAEMIA 305 0.0054
710 BLOOD TEST ABNORMAL 76 0.0054
711 CIRCULATORY COLLAPSE 92 0.0054
712 DRUG ABUSE 449 0.0054
713 GALLBLADDER DISORDER 96 0.0054
714 QUALITY OF LIFE DECREASED 72 0.0054
715 INTENTIONAL PRODUCT USE ISSUE 469 0.0053
716 ABSCESS 85 0.0053
717 DERMATITIS ALLERGIC 67 0.0053
718 TYPE 2 DIABETES MELLITUS 179 0.0053
719 INTENTIONAL PRODUCT MISUSE 465 0.0053
720 PULMONARY MASS 79 0.0053
721 INJECTION SITE REACTION 364 0.0053
722 THROAT TIGHTNESS 143 0.0053
723 PRURITUS 2028 0.0053
724 BLOOD ALKALINE PHOSPHATASE INCREASED 131 0.0053
725 ADVERSE DRUG REACTION 473 0.0053
726 GASTRIC ULCER 100 0.0053
727 THROMBOSIS 421 0.0052
728 OESOPHAGITIS 57 0.0052
729 NERVOUSNESS 272 0.0052
730 SEPTIC SHOCK 225 0.0052
731 INJECTION SITE HAEMATOMA 75 0.0052
732 FEAR 139 0.0052
733 TREATMENT NONCOMPLIANCE 282 0.0051
734 BLINDNESS 210 0.0051
735 ANGER 174 0.0051
736 CARDIOMYOPATHY 76 0.0051
737 EYE DISORDER 167 0.0051
738 ABDOMINAL DISTENSION 530 0.0051
739 SKIN LESION 139 0.0051
740 LYMPHADENOPATHY 179 0.0051
741 THERAPEUTIC PRODUCT EFFECT DECREASED 225 0.0050
742 INJECTION SITE INDURATION 65 0.0050
743 COUGH 1405 0.0050
744 EMOTIONAL DISORDER 154 0.0050
745 LIVER FUNCTION TEST INCREASED 107 0.0050
746 HYPERSENSITIVITY 923 0.0050
747 HERNIA 96 0.0050
748 ALANINE AMINOTRANSFERASE INCREASED 304 0.0049
749 OBSTRUCTIVE AIRWAYS DISORDER 55 0.0049
750 TENDON RUPTURE 61 0.0049
751 SYNOVITIS 89 0.0049
752 DIARRHOEA 3185 0.0049
753 STOMATITIS 299 0.0049
754 PRODUCTIVE COUGH 235 0.0049
755 DIABETES MELLITUS 375 0.0049
756 FLATULENCE 278 0.0049
757 DEVICE BREAKAGE 199 0.0049
758 C-REACTIVE PROTEIN INCREASED 178 0.0049
759 SKIN DISORDER 163 0.0049
760 INJECTION SITE DISCOLOURATION 61 0.0049
761 HAND DEFORMITY 64 0.0049
762 SKIN DISCOLOURATION 224 0.0049
763 DYSPNOEA 2757 0.0049
764 SWOLLEN TONGUE 152 0.0049
765 PRODUCT DOSE OMISSION ISSUE 1431 0.0049
766 WHEEZING 288 0.0049
767 TASTE DISORDER 98 0.0048
768 LOCAL SWELLING 84 0.0048
769 BLOOD TRIGLYCERIDES INCREASED 85 0.0048
770 PHARYNGEAL OEDEMA 74 0.0048
771 INTENTIONAL DOSE OMISSION 137 0.0048
772 DEVICE LEAKAGE 208 0.0048
773 LOWER RESPIRATORY TRACT INFECTION 218 0.0048
774 BONE PAIN 279 0.0048
775 PROSTATIC SPECIFIC ANTIGEN INCREASED 65 0.0047
776 DECREASED APPETITE 1095 0.0047
777 HAIR TEXTURE ABNORMAL 63 0.0047
778 ASPARTATE AMINOTRANSFERASE INCREASED 250 0.0047
779 CYANOSIS 74 0.0047
780 FRACTURE 89 0.0047
781 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0047
782 GENERAL PHYSICAL HEALTH DETERIORATION 541 0.0047
783 ILL-DEFINED DISORDER 283 0.0047
784 PROCEDURAL PAIN 129 0.0046
785 BLISTER 260 0.0046
786 CATARACT 275 0.0046
787 COLITIS 174 0.0046
788 SWELLING FACE 297 0.0046
789 SECRETION DISCHARGE 57 0.0045
790 LIP SWELLING 151 0.0045
791 MULTIPLE FRACTURES 74 0.0045
792 DRUG INEFFECTIVE 5932 0.0045
793 OFF LABEL USE 3926 0.0045
794 ASTHMA 506 0.0045
795 MOOD ALTERED 122 0.0045
796 HEPATIC CIRRHOSIS 84 0.0045
797 ABDOMINAL PAIN 1026 0.0044
798 TARDIVE DYSKINESIA 124 0.0044
799 GASTROENTERITIS 64 0.0044
800 BLOOD POTASSIUM INCREASED 71 0.0044
801 INJECTION SITE ERYTHEMA 542 0.0044
802 HYPOACUSIS 188 0.0044
803 BLOOD COUNT ABNORMAL 66 0.0043
804 TOOTH LOSS 90 0.0043
805 FULL BLOOD COUNT DECREASED 87 0.0043
806 PARAESTHESIA ORAL 62 0.0043
807 PLATELET COUNT INCREASED 56 0.0043
808 PHOTOSENSITIVITY REACTION 70 0.0042
809 THERAPY INTERRUPTED 301 0.0042
810 THIRST 75 0.0042
811 AKATHISIA 57 0.0042
812 TREATMENT FAILURE 346 0.0042
813 HUNGER 58 0.0042
814 PRODUCT USE IN UNAPPROVED INDICATION 1030 0.0042
815 DRUG EFFECT INCOMPLETE 150 0.0041
816 URTICARIA 691 0.0041
817 EXTRA DOSE ADMINISTERED 167 0.0041
818 LUNG DISORDER 202 0.0041
819 ACUTE MYOCARDIAL INFARCTION 121 0.0041
820 MEDICATION ERROR 228 0.0041
821 HAEMOGLOBIN DECREASED 419 0.0041
822 DEMENTIA 114 0.0041
823 CEREBROVASCULAR ACCIDENT 690 0.0041
824 BRONCHOSPASM 58 0.0041
825 HYPERGLYCAEMIA 148 0.0041
826 DRUG PRESCRIBING ERROR 78 0.0041
827 HAEMATURIA 139 0.0041
828 PRODUCT ADMINISTRATION ERROR 82 0.0041
829 LUNG INFECTION 63 0.0041
830 LEUKOPENIA 202 0.0040
831 PRESYNCOPE 98 0.0040
832 ANAPHYLACTIC REACTION 222 0.0040
833 BLOOD GLUCOSE ABNORMAL 73 0.0039
834 RASH 1714 0.0039
835 INJECTION SITE BRUISING 313 0.0039
836 SHOCK 90 0.0039
837 PNEUMOTHORAX 62 0.0039
838 LACRIMATION INCREASED 118 0.0039
839 PANCREATITIS 205 0.0039
840 INJURY 272 0.0039
841 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 275 0.0039
842 DEAFNESS 100 0.0038
843 RENAL FAILURE ACUTE 162 0.0038
844 CARDIAC DISORDER 357 0.0038
845 ERYTHEMA 782 0.0038
846 HYPERTHYROIDISM 55 0.0038
847 ACUTE RESPIRATORY DISTRESS SYNDROME 67 0.0038
848 RASH PRURITIC 204 0.0038
849 DYSGEUSIA 279 0.0038
850 PULMONARY OEDEMA 168 0.0037
851 PRURITUS GENERALISED 81 0.0037
852 DYSPNOEA EXERTIONAL 141 0.0037
853 RENAL DISORDER 174 0.0037
854 HOSPITALISATION 568 0.0037
855 VISUAL ACUITY REDUCED 122 0.0037
856 PSORIATIC ARTHROPATHY 149 0.0037
857 WRONG TECHNIQUE IN DRUG USAGE PROCESS 133 0.0037
858 RECTAL HAEMORRHAGE 157 0.0037
859 PALLOR 99 0.0036
860 INCORRECT ROUTE OF DRUG ADMINISTRATION 130 0.0036
861 INJECTION SITE URTICARIA 89 0.0036
862 SKIN CANCER 78 0.0036
863 ERUCTATION 70 0.0036
864 CONJUNCTIVITIS 67 0.0036
865 SYSTEMIC LUPUS ERYTHEMATOSUS 128 0.0036
866 ATRIAL FIBRILLATION 351 0.0036
867 RASH ERYTHEMATOUS 172 0.0036
868 DRUG ADMINISTRATION ERROR 110 0.0036
869 DERMATITIS 75 0.0036
870 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 644 0.0036
871 METABOLIC ACIDOSIS 114 0.0036
872 PERICARDIAL EFFUSION 82 0.0035
873 DRUG-INDUCED LIVER INJURY 110 0.0035
874 PELVIC PAIN 63 0.0035
875 CORONARY ARTERY DISEASE 105 0.0035
876 ANAEMIA 651 0.0034
877 RASH MACULAR 119 0.0034
878 PRODUCT AVAILABILITY ISSUE 77 0.0034
879 MULTI-ORGAN FAILURE 58 0.0034
880 ADVERSE EVENT 306 0.0033
881 PRODUCT ADHESION ISSUE 118 0.0033
882 PRODUCT USE ISSUE 620 0.0033
883 BLOOD BILIRUBIN INCREASED 89 0.0033
884 AGEUSIA 82 0.0033
885 PRODUCT SUBSTITUTION ISSUE 189 0.0033
886 MOUTH ULCERATION 69 0.0033
887 MYOCARDIAL INFARCTION 568 0.0033
888 INTERNATIONAL NORMALISED RATIO INCREASED 92 0.0032
889 INTENTIONAL SELF-INJURY 65 0.0032
890 PULMONARY HYPERTENSION 67 0.0032
891 BLOOD CREATININE INCREASED 210 0.0032
892 RENAL IMPAIRMENT 270 0.0032
893 DISEASE PROGRESSION 380 0.0032
894 HEPATIC FAILURE 96 0.0032
895 EMOTIONAL DISTRESS 384 0.0032
896 EYE SWELLING 118 0.0032
897 ISCHAEMIC STROKE 56 0.0031
898 OSTEONECROSIS 103 0.0031
899 RASH PAPULAR 70 0.0031
900 HAEMATOCHEZIA 172 0.0031
901 ANAPHYLACTIC SHOCK 80 0.0031
902 LIVER DISORDER 137 0.0031
903 EPISTAXIS 230 0.0031
904 GOUT 55 0.0031
905 DRUG DEPENDENCE 490 0.0030
906 CARDIOVASCULAR DISORDER 76 0.0030
907 CARDIAC FAILURE CONGESTIVE 239 0.0030
908 ABDOMINAL PAIN LOWER 75 0.0030
909 FREQUENT BOWEL MOVEMENTS 80 0.0030
910 PRODUCT PRESCRIBING ISSUE 64 0.0029
911 BLOOD GLUCOSE DECREASED 141 0.0029
912 INCREASED APPETITE 56 0.0029
913 HYPOGLYCAEMIA 142 0.0029
914 PLATELET COUNT DECREASED 310 0.0029
915 FAECES DISCOLOURED 63 0.0029
916 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
917 ARRHYTHMIA 136 0.0029
918 NEUTROPHIL COUNT DECREASED 117 0.0029
919 INTENTIONAL DRUG MISUSE 60 0.0029
920 INJECTION SITE PRURITUS 192 0.0029
921 EXTRAPYRAMIDAL DISORDER 71 0.0029
922 CEREBRAL HAEMORRHAGE 102 0.0028
923 ANGINA PECTORIS 81 0.0028
924 PRODUCT PHYSICAL ISSUE 57 0.0028
925 BONE DENSITY DECREASED 88 0.0028
926 HAEMOPTYSIS 78 0.0028
927 GASTROINTESTINAL HAEMORRHAGE 228 0.0027
928 GLOSSODYNIA 61 0.0027
929 SKIN EXFOLIATION 229 0.0027
930 PRODUCT DISPENSING ERROR 59 0.0027
931 PLEURAL EFFUSION 164 0.0027
932 LACTIC ACIDOSIS 87 0.0027
933 ECZEMA 140 0.0027
934 INCORRECT DOSE ADMINISTERED BY DEVICE 70 0.0027
935 INJECTION SITE PAIN 819 0.0027
936 PANCREATITIS ACUTE 60 0.0027
937 PLASMA CELL MYELOMA 104 0.0027
938 TRANSAMINASES INCREASED 59 0.0027
939 INJECTION SITE SWELLING 203 0.0026
940 PSORIASIS 345 0.0026
941 PAIN OF SKIN 71 0.0026
942 BREAST CANCER FEMALE 70 0.0026
943 HEPATITIS 66 0.0026
944 OCULAR HYPERAEMIA 122 0.0026
945 ABORTION SPONTANEOUS 103 0.0026
946 HYPERKALAEMIA 90 0.0026
947 JAUNDICE 69 0.0026
948 BLOOD GLUCOSE INCREASED 481 0.0026
949 INJECTION SITE RASH 78 0.0025
950 DRY SKIN 339 0.0025
951 EYE IRRITATION 146 0.0025
952 DISEASE RECURRENCE 120 0.0025
953 HAEMORRHAGE 263 0.0025
954 RASH GENERALISED 65 0.0025
955 BREAST CANCER 232 0.0025
956 INCORRECT DOSE ADMINISTERED 555 0.0024
957 ACNE 182 0.0024
958 DEATH 2056 0.0024
959 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
960 CARDIAC FAILURE 189 0.0024
961 NEOPLASM MALIGNANT 157 0.0024
962 DIABETIC KETOACIDOSIS 56 0.0023
963 ASCITES 68 0.0023
964 PRODUCT QUALITY ISSUE 314 0.0023
965 THROMBOCYTOPENIA 255 0.0023
966 NEEDLE ISSUE 66 0.0023
967 EYE PRURITUS 75 0.0022
968 INCORRECT DRUG ADMINISTRATION DURATION 62 0.0022
969 MATERNAL EXPOSURE DURING PREGNANCY 194 0.0022
970 INJECTION SITE HAEMORRHAGE 172 0.0022
971 NEUTROPENIA 291 0.0021
972 EXPIRED PRODUCT ADMINISTERED 70 0.0021
973 ANGIOEDEMA 93 0.0021
974 PREMATURE BABY 62 0.0021
975 NO ADVERSE EVENT 367 0.0020
976 PANCYTOPENIA 109 0.0019
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 388 0.0019
978 SKIN BURNING SENSATION 136 0.0019
979 VAGINAL HAEMORRHAGE 76 0.0017
980 SKIN IRRITATION 79 0.0017
981 HEPATIC FUNCTION ABNORMAL 63 0.0017
982 LUNG NEOPLASM MALIGNANT 65 0.0016
983 ACCIDENTAL EXPOSURE TO PRODUCT 145 0.0014
984 COLITIS ULCERATIVE 62 0.0014
985 EXPOSURE DURING PREGNANCY 81 0.0013
986 FEBRILE NEUTROPENIA 85 0.0013
987 FOETAL EXPOSURE DURING PREGNANCY 103 0.0013
988 DERMATITIS ATOPIC 60 0.0011
989 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
990 PROSTATE CANCER 79 0.0010
991 DRUG DOSE OMISSION BY DEVICE 71 0.0009
992 DEVICE DIFFICULT TO USE 58 0.0009
993 PRODUCT STORAGE ERROR 69 0.0008